Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium

American Journal of Transplantation

Volumn 15, Issue 3, 2015, Pages 606-617

  Pantin, J M ^a,b   Hoyt, R F ^b,c   Aras, O ^d   Sato, N ^e   Chen, M Y ^b   Hunt, T ^b   Clevenger, R ^b   Eclarinal, P ^c   Adler, S ^c   Choyke, P ^e   Childs, Richard W ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

animal models: porcine; basic (laboratory) research science; bone marrow; clinical research practice; diagnostic techniques and imaging: positron emission tomography; graft survival; graft versus host disease (GVHD); hematology oncology; hematopoietic stem cell transplantation; monitoring: physiologic; xenotransplantation

Indexed keywords

CD133 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; IOPAMIDOL; PROTAMINE SULFATE; UNCLASSIFIED DRUG; ZIRCONIUM 89; ZIRCONIUM DERIVATIVE; RADIOISOTOPE; ZIRCONIUM;

ARTERIAL PRESSURE; ARTICLE; CELL LABELING; CELL SURVIVAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXTRAVASATION; HEMATOPOIETIC STEM CELL; HEMODYNAMIC MONITORING; HUMAN; HUMAN CELL; HYPOTENSION; HYPOXEMIA; INTERNAL ILIAC ARTERY; ISOTOPE LABELING; LUNG EMBOLISM; PORCINE MODEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; TACHYCARDIA; VENOUS CIRCULATION; ANIMAL; ANIMAL MODEL; BONE; CHEMISTRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MULTIMODAL IMAGING; PIG;

ANIMALS; BONE AND BONES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MODELS, ANIMAL; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; SWINE; TOMOGRAPHY, X-RAY COMPUTED; ZIRCONIUM;

EID: 84923302951     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13007     Document Type: Article

References (42)

1. Gholamrezanezhad A, Mirpour S, Bagheri M, Malekzadeh R, Saghari M., Cytotoxicity of 111In-oxine on mesenchymal stem cells: A time dependent effect. Eur J Nucl Med Mol Imaging 2008; 35: S317-S317.
2. Gildehaus FJ, Haasters F, Drosse I, et al. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol Imaging Biol 2011; 13: 1204-1214.
3. Rahmim A, Zaidi H., PET versus SPECT: Strengths, limitations and challenges. Nucl Med Commun 2008; 29: 193-207.
4. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002-5012.
5. Lapidot T, Dar A, Kollet O., How do stem cells find their way home ? Blood 2005; 106: 1901-1910.
6. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009; 18: 683-691.
7. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-1618.
8. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347.
9. Rocha V, Crotta A, Ruggeri A, et al. Double cord blood transplantation: Extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol 2010; 23: 223-229.
10. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID., Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232-236.
11. Duchez P, Chevaleyre J, Vlaski M, et al. Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantation. Cell Transplant 2012; 21: 2517-2521.
12. Xia LJ, McDaniel JM, Yago T, Doeden A, McEver RP., Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 2004; 104: 3091-3096.
13. Robinson SN, Thomas MW, Simmons PJ, et al. Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment. Cytotherapy 2014; 16: 84-89.
14. Frassoni F, Gualandi F, Podesta M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol 2008; 9: 831-839.
15. Morrison M, Samwick AA., Intramedullary (sternal) transfusion of human bone marrow: Preliminary report. J Am Med Assoc 1940; 115: 1708-1711.
16. Okada M, Yoshihara S, Taniguchi K, et al. Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: A phase I study. Biol Blood Marrow Transplant 2012; 18: 633-639.
17. Brunstein CG, Barker JN, Weisdorf DJ, et al. Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transpl 2009; 43: 935-940.
18. Hagglund H, Ringden O, Agren B, et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transpl 1998; 21: 331-335.
19. Li Q, Hisha H, Yasumizu R, et al. Analyses of very early hemopoietic regeneration after bone marrow transplantation: Comparison of intravenous and intrabone marrow routes. Stem Cells 2007; 25: 1186-1194.
20. Mazurier F, Doedens M, Gan OI, Dick JE., Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959-963.
21. Omae M, Inaba M, Sakaguchi Y, et al. Long-term maintenance of donor-derived hematopoiesis by intra-bone marrow-bone marrow transplantation. Stem Cells Dev 2008; 17: 291-302.
22. Wang JF, Kimura T, Asada R, et al. SCID-repopulating cell activity of human cord blood-derived CD34(-) cells assured by intra-bone marrow injection. Blood 2003; 101: 2924-2931.
23. Kimura T, Matsuoka Y, Murakami M, et al. In vivo dynamics of human cord blood-derived CD34(-) SCID-repopulating cells using intra-bone marrow injection. Leukemia 2010; 24: 162-168.
24. Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003; 101: 2905-2913.
25. Cameron JL, Fontanarosa PB, Passalaqua AM., A comparative study of peripheral to central circulation delivery times between intraosseous and intravenous injection using a radionuclide technique in normovolemic and hypovolemic canines. J Emerg Med 1989; 7: 123-127.
26. Schoffstall JM, Spivey WH, Davidheiser S, Lathers CM., Intraosseous crystalloid and blood infusion in a swine model. J Trauma 1989; 29: 384-387.
27. Hasan MY, Kissoon N, Fiallos M, Abdelmoneim T, Johnson L, Murphy S., Incidence of fat and bone marrow embolism with the use of intraosseous infusion during cardio-pulmonary resuscitation. Pediatrics 1997; 100: 455-455.
28. Orlowski JP, Julius CJ, Petras RE, Porembka DT, Gallagher JM., The safety of intraosseous infusions-Risks of fat and bone-marrow emboli to the lungs. Ann Emerg Med 1989; 18: 1062-1068.
29. Upton RN., Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. J Pharmacol Toxicol Methods 2008; 58: 198-205.
30. Warrens AN, Simon AR, Theodore PR, Sykes M., Human-porcine receptor-ligand compatibility within the immune system: Relevance for xenotransplantation. Xenotransplantation 1999; 6: 75-78.
31. Fujiki Y, Fukawa K, Kameyama K, et al. Successful multilineage engraftment of human cord blood cells in pigs after in utero transplantation. Transplantation 2003; 75: 916-922.
32. Pawelczyk E, Jordan EK, Balakumaran A, et al. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS ONE 2009; 4: e6712.
33. Regan DM, Wofford JD, Wall DA., Comparison of cord blood thawing methods on cell recovery, potency, and infusion. Transfusion 2010; 50: 2670-2675.
34. Zhang Z, Alrubeai M, Thomas CR., Estimation of disruption of animal-cells by turbulent capillary-flow. Biotechnol Bioeng 1993; 42: 987-993.
35. Laforest R, Liu X., Image quality with non-standard nuclides in PET. Q J Nucl Med Mol Imaging 2008; 52: 151-158.
36. van Os R, Ausema A, Dontje B, van Riezen M, van Dam G, de Haan G., Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration. Exp Hematol 2010; 38: 1115-1123.
37. Massollo M, Podesta M, Marini C, et al. Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. Exp Hematol 2010; 38: 968-977.
38. Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-2711.
39. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE., Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
40. Miyake T, Inaba M, Fukui J, et al. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: Involvement of bone marrow stromal cells. Clin Exp Immunol 2008; 152: 153-162.
41. Cui Y, Nakamura S, Shi M, et al. A successful haploidentical bone marrow transplantation method in rabbits: Perfusion method plus intra-bone marrow-bone marrow transplantation. Transpl Immunol 2010; 24: 33-39.
42. Esumi T, Inaba M, Ichioka N, Kushida T, Iida H, Ikehara S., Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 2003; 76: 1543-1548.